Evidence of Nonadherence in Cases of Pseudoresistant Hypertension

References

• Virani SS, Alonso A, Benjamin EJ, et al. Heart Disease and Stroke Statistics-2020 Update: a Report from the American Heart Association. Circulation. 2020;141(9):e139–e596. doi:10.1161/CIR.0000000000000757.
   PubMed Web of Science ®Google Scholar
• Picon RV, Fuchs FD, Moreira LB, Riegel G, Fuchs SC. Trends in prevalence of hypertension in Brazil: a systematic review with meta-analysis. PLoS One. 2012;7(10):e48255. doi:10.1371/journal.pone.0048255.
   Web of Science ®Google Scholar
• Malachias M, Plavnik FL, Machado CA, Malta D, Scala LCN, Fuchs S. 7th Brazilian Guideline of Arterial Hypertension. Chapter 1 – concept, Epidemiology and Primary Prevention. Arq Bras Cardiol. 2016;107(3 Suppl 3):1–16. doi:10.5935/abc.20160151.
   Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American college of cardiology/american heart association task force on clinical practice guidelines. Hypertension. 2018;71(6):e13–e115. doi:10.1161/HYP.0000000000000065.
   PubMed Web of Science ®Google Scholar
• Yugar-Toledo JC, Moreno Júnior H, Gus M, et al. Brazilian Position Statement on Resistant Hypertension - 2020. Arq Bras Cardiol. 2020;114(3):576–596. doi:10.36660/abc.20200198.
   Web of Science ®Google Scholar
• Carey RM, Calhoun DA, Bakris GL, et al. Resistant hypertension: detection, evaluation, and management a scientific statement from the american heart association. Hypertension. 2018;72(5):e53–e90. doi:10.1161/HYP.0000000000000084.
   PubMed Web of Science ®Google Scholar
• Alessi A, Brandão AA, Coca A, Cordeiro AC, Nogueira AR. First Brazilian position on resistant hypertension. Arq Bras Cardiol. 2012;99(1):576–585. doi:10.1590/s0066-782x2012000700002.
   PubMed Web of Science ®Google Scholar
• Burnier M, Wuerzner G, Struijker-Boudier H, Urquhart J. Measuring, analyzing, and managing drug adherence in resistant hypertension. Hypertension. 2013;62(2):218–225. doi:10.1161/HYPERTENSIONAHA.113.00687.
   PubMed Web of Science ®Google Scholar
• Ceral J, Habrdova V, Vorisek V, Bima M, Pelouch R, Solar M. Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy. Hypertens Res. 2011;34(1):87–90. doi:10.1038/hr.2010.183.
   PubMed Web of Science ®Google Scholar
• Hameed MA, Tebbit L, Jacques N, Thomas M, Dasgupta I. Non-adherence to antihypertensive medication is very common among resistant hypertensives: results of a directly observed therapy clinic. J Hum Hypertens. 2016;30(2):83–89. doi:10.1038/jhh.2015.38.
   PubMed Web of Science ®Google Scholar
• Schulz M, Krueger K, Schuessel K, et al. Medication adherence and persistence according to different antihypertensive drug classes: a retrospective cohort study of 255,500 patients.Int J Cardiology. 2016;220:668–676. doi:10.1016/j.ijcard.2016.06.263.
   PubMed Web of Science ®Google Scholar
• Avataneo V, De Nicolò A, Rabbia F, et al. Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence. Br J Clin Pharmacol. 2018;84(11):2535–2543. doi:10.1111/bcp.13706.
   Web of Science ®Google Scholar
• Durand H, Hayes P, Morrissey EC, et al. Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis. J Hypertens. 2017;35(12):2346–2357. doi:10.1097/HJH.0000000000001502.
   PubMed Web of Science ®Google Scholar
• Hayes P, Casey M, Glynn LG, et al. Prevalence of treatment-resistant hypertension after considering pseudo-resistance and morbidity: a cross-sectional study in Irish primary care. Br J Gen Pract. 2018;68(671):e394–e400. doi:10.3399/bjgp18X696221.
   PubMed Web of Science ®Google Scholar
• Burnier M. Drug Adherence in Hypertension. Pharmacol Res. 2017;125(Pt B):142–149. doi:10.1016/j.phrs.2017.08.015.
   PubMed Web of Science ®Google Scholar
• Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705. doi:10.1111/j.1365-2125.2012.04167.x.
   PubMed Web of Science ®Google Scholar
• Ruzicka M, Hiremath S. Can drugs work in patients who do not take them? The problem of non-adherence in resistant hypertension. Curr Hypertens Rep. 2015;17(9):579. doi:10.1007/s11906-015-0579-4.
   PubMed Web of Science ®Google Scholar
• Mukhtar O, Weinman J, Jackson SHD. Intentional non-adherence to medications by older adults. Drugs Aging. 2016;220(3):668.
   Google Scholar
• Hayen A, Bell K, Glasziou P, Neal B, Irwig L. Monitoring adherence to medication by measuring change in blood pressure. Hypertension. 2010;56(4):612–616. doi:10.1161/HYPERTENSIONAHA.110.153817.
   Web of Science ®Google Scholar
• Rabbia F, Fulcheri C, Di Monaco S, et al. Adherence to antihypertensive therapy and therapeutic dosage of antihypertensive drugs. High Blood Press Cardiovasc Prev. 2016;23(4):341–345. doi:10.1007/s40292-016-0158-z.
   Google Scholar
• Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348–354. doi:10.1111/j.1751-7176.2008.07572.x.
   PubMed Web of Science ®Google Scholar
• Berlowitz DR, Foy CG, Kazis LE, et al. For the SPRINT study research group. impact of intensive blood pressure therapy on patient-reported outcomes: outcomes results from the SPRINT study. N Engl J Med. 2017;377(8):733–744. doi:10.1056/NEJMoa1611179.
   PubMed Web of Science ®Google Scholar
• Bress AP, Bellows BK, King JB, et al. For the SPRINT Research Group and the SPRINT Economics and Health Related Quality of Life Subcommittee. Cost-Effectiveness of Intensive versus Standard Blood Pressure Control. N Engl J Med. 2017;377(8):745–755. doi:10.1056/NEJMsa1616035.
   PubMed Web of Science ®Google Scholar
• de la Sierra A, Segura J, Banegas JR, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension. 2011;57(5):898–902. doi:10.1161/HYPERTENSIONAHA.110.168948.
   PubMed Web of Science ®Google Scholar
• Salles GF, Cardoso CR, Muxfeldt ES. Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med. 2008;168(21):2340–2346. doi:10.1001/archinte.168.21.2340.
   PubMedGoogle Scholar
• Hermida RC, Ayala DE, Mojon A, Fernandez JR. Effects of time of antihypertensive treatment on ambulatory blood pressure and clinical characteristics of subjects with resistant hypertension. Am J Hypertens. 2010;23(4):432–439. doi:10.1038/ajh.2009.260.
   Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fernandez JR, et al. Bedtime blood pressure chronotherapy significantly improves hypertension management. Heart Fail Clin. 2017;13(4):759–773. doi:10.1016/j.hfc.2017.05.010.
   Web of Science ®Google Scholar
• Judd E, Calhoun DA. Apparent and true resistant hypertension: definition, prevalence and outcomes. J Hum Hypertens. 2014;28(8):463–468. doi:10.1038/jhh.2013.140.
   PubMed Web of Science ®Google Scholar
• Sarafidis PA, Georgianos P, Bakris GL. Resistant hypertension—its identification and epidemiology. Nat Rev Nephrol. 2013;9(1):51–58. doi:10.1038/nrneph.2012.260.
   PubMed Web of Science ®Google Scholar
• Bhatt H, Siddiqui M, Judd E, Oparil S, Calhoun D. Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurement. J Am Soc Hypertens. 2016;10(6):493–499. doi:10.1016/j.jash.2016.03.186.
   PubMed Web of Science ®Google Scholar
• Muxfeldt ES, de Souza F, Salles GF. Resistant hypertension: a practical clinical approach. J Hum Hypertens. 2013;27(11):657–662. doi:10.1038/jhh.2013.34.
   Web of Science ®Google Scholar
• Garg JP, Elliott WJ, Folker IM, Black HR. RUSH University Hypertension Service. Resistant hypertension revisited: a comparison of two university-based cohorts. Am J Hypertens. 2005;18(5Pt.1):619–626. doi:10.1016/j.amjhyper.2004.11.021.
   Web of Science ®Google Scholar
• Kociánová E, Václavík J, Tomková J, et al. Heart rate is a useful marker of adherence to beta-blocker treatment in hypertension. Blood Press. 2017;26(5):311–318. doi:10.1080/08037051.2017.1346458.
   PubMed Web of Science ®Google Scholar
• Udovcic M, Pena RH, Patham B, Tabatabai L, Kansara A. Hypothyroidism and the Heart. Methodist Debakey Cardiovasc J. 2017;13(2):55–59. doi:10.14797/mdcj-13-2-55.
   PubMedGoogle Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39(33):3021–3104. doi:10.1093/eurheartj/ehy339.
   PubMed Web of Science ®Google Scholar
• Dosse C, Cesarino CB, Martin JF, Castedo MC. Factors associated to patients’ noncompliance with hypertension treatment. Rev Lat Am Enfermagem. 2009;17(2):201–206. doi:10.1590/s0104-11692009000200010.
   Web of Science ®Google Scholar
• Pappaccogli M, Di Monaco S, Coralie G, et al. Predictors of blood pressure control in patients with resistant hypertension after intensive management in two expert centres: the Brussels-Torino experience. Blood Press. 2019;28(5):336–344. doi:10.1080/08037051.2019.1633908.
   PubMed Web of Science ®Google Scholar
• Bayer R, Wilkinson D. Directly observed therapy for tuberculosis: history of an idea. Lancet. 1995;345(8964):1545–1548. doi:10.1016/s0140-6736(95)91090-5.
   Web of Science ®Google Scholar
• Van der Laan DM, Elders PJM, Boons CCLM, Beckeringh JJ, Nijpels G, Hugtenburg JG. Factors associated with antihypertensive medication non-adherence: a systematic review. J Hum Hypertens. 2017;31:687–694. doi:10.1038/jhh.2017.48.
   PubMed Web of Science ®Google Scholar
• Elliott WJ. What factors contribute to the inadequate control of elevated blood pressure? J Clin Hypertens. 2008;10(suppl 1):20–26. doi:10.1111/j.1524-6175.2007.08028.x.
   PubMed Web of Science ®Google Scholar